Vaxcyte, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2020-06-11

Reporting Person: Fairman Jeff (VP, Research)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	391227	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.04	2025-04-23	Common Stock (21509)		Direct
Stock Option (right to buy)	$1.79	2027-05-17	Common Stock (92369)		Direct
Stock Option (right to buy)	$2.03	2028-07-23	Common Stock (97806)		Direct
Stock Option (right to buy)	$5.35	2030-04-17	Common Stock (65202)		Direct

Footnotes

F1: The shares subject to the option are fully vested and exercisable.

F2: 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48th of the shares vest monthly thereafter.

F3: 1/4 of the shares subject to the option vested on July 24, 2019, and 1/48 of the shares vest monthly thereafter.

F4: 1/4 of the shares subject to the option vest on March 20, 2021, and 1/48 of the shares vest monthly thereafter.